Home > Insider Trading > Filing (0001209191-19-055470)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1406338	Amit Sachdev	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp, Chief Patient Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-11-04	2,155	$91.05	35,571	No	4	M	Direct
Common Stock	Acquisiton	2019-11-04	1,942	$86.52	37,513	No	4	M	Direct
Common Stock	Disposition	2019-11-04	500	$199.77	37,013	No	4	S	Direct
Common Stock	Disposition	2019-11-04	2,497	$200.12	34,516	No	4	S	Direct
Common Stock	Disposition	2019-11-04	1,100	$201.10	33,416	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2019-11-04	2,155	$0.00	2,155	$91.05
Common Stock	Stock Option (Right to Buy)	Disposition	2019-11-04	1,942	$0.00	1,942	$86.52

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,156		2026-02-01	No	4	M	Direct
9,708		2027-02-02	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	882	Indirect	401(k)
Common Stock	18,964	Indirect	Held in trust

Footnotes

Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $199.77 (range $199.76 to $199.79).
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $200.12 (range $199.83 to $200.53).
Open market sales reported on this line occurred at a weighted average price of $201.10 (range $200.86 to $201.26).
The option vests in 16 quarterly installments from 02/02/2016.
The option vests in 16 quarterly installments from 02/03/2017.